SAT-335-A simple biomarker panel predictive of advanced fibrosis in patients with non-alcoholic steatohepatitis

2019 ◽  
Vol 70 (1) ◽  
pp. e787
Author(s):  
Zobair Younossi ◽  
Azza Karrar ◽  
Maria Stepanova ◽  
Brian Lam ◽  
Sean Felix ◽  
...  
Keyword(s):  
Advanced Fibrosis ◽  
Biomarker Panel ◽  
Alcoholic Steatohepatitis

scholarly journals Portal lymphadenopathy predicts non-alcoholic steatohepatitis and advanced fibrosis in non-alcoholic fatty liver disease

PLoS ONE ◽  
2018 ◽  
Vol 13 (11) ◽  
pp. e0207479 ◽  
Author(s):  
Saleh Daher ◽  
Namma Lev Cohen ◽  
Muhammad Massarwa ◽  
Mahmud Mahamid ◽  
Mira Nasser ◽  
...  
Keyword(s):  
Liver Disease ◽  
Fatty Liver ◽  
Fatty Liver Disease ◽  
Advanced Fibrosis ◽  
Alcoholic Fatty Liver ◽  
Alcoholic Steatohepatitis ◽  
Alcoholic Fatty Liver Disease

Systematic review and meta-analysis of FIB-4 for the diagnosis of advanced fibrosis due to non-alcoholic steatohepatitis

2020 ◽  
Vol 73 ◽  
pp. S424
Author(s):  
Mazen Noureddin ◽  
Amber L. Martin ◽  
Samantha Martel ◽  
Robert Myers ◽  
Angela Nitka ◽  
...  
Keyword(s):  
Systematic Review ◽  
Meta Analysis ◽  
Advanced Fibrosis ◽  
Alcoholic Steatohepatitis

Unconjugated bilirubin, a potent endogenous antioxidant, is decreased in patients with non-alcoholic steatohepatitis and advanced fibrosis

2013 ◽  
Vol 28 (7) ◽  
pp. 1202-1208 ◽  
Author(s):  
Federico Salomone ◽  
Giovanni Li Volti ◽  
Chiara Rosso ◽  
Giuseppe Grosso ◽  
Elisabetta Bugianesi
Keyword(s):  
Unconjugated Bilirubin ◽  
Advanced Fibrosis ◽  
Alcoholic Steatohepatitis ◽  
Endogenous Antioxidant

scholarly journals Serious complications due to study-mandated liver biopsies in phase 3 trials for patients with advanced fibrosis due to non-alcoholic steatohepatitis

2020 ◽  
Vol 73 ◽  
pp. S164
Author(s):  
Quentin Anstee ◽  
Keyur Patel ◽  
Castera Laurent ◽  
Mitchell Shiffman ◽  
Mang M ◽  
...  
Keyword(s):  
Advanced Fibrosis ◽  
Phase 3 ◽  
Alcoholic Steatohepatitis ◽  
Liver Biopsies

scholarly journals Randomised clinical study: GR-MD-02, a galectin-3 inhibitor, vs. placebo in patients having non-alcoholic steatohepatitis with advanced fibrosis

2016 ◽  
Vol 44 (11-12) ◽  
pp. 1183-1198 ◽  
Author(s):  
S. A. Harrison ◽  
S. R. Marri ◽  
N. Chalasani ◽  
R. Kohli ◽  
W. Aronstein ◽  
...  
Keyword(s):  
Clinical Study ◽  
Advanced Fibrosis ◽  
Alcoholic Steatohepatitis ◽  
Galectin 3

Serum biomarkers in type 2 diabetic patients with non-alcoholic steatohepatitis and advanced fibrosis

2012 ◽  
Vol 43 (5) ◽  
pp. 508-515 ◽  
Author(s):  
Nathalie Carvalho Leite ◽  
Gil Fernando Salles ◽  
Claudia Regina Lopes Cardoso ◽  
Cristiane Alves Villela-Nogueira
Keyword(s):  
Serum Biomarkers ◽  
Diabetic Patients ◽  
Advanced Fibrosis ◽  
Type 2 Diabetic Patients ◽  
Alcoholic Steatohepatitis ◽  
Type 2 Diabetic
Sign in / Sign up

Export Citation Format

Share Document